Search
07/07/2023
Increased Ca2+ Transient Underlies RyR2-Related Left Ventricular Noncompaction
Ni, MK, Li, YH, Wei, JH, Song, ZP, Wang, H, Yao, JJ, Chen, YX, Belke, D, Estillore, JP, Wang, RW, Vallmitjana, A, Benitez, R, Hove-Madsen, L, Feng, W, Chen, J, Roston, TM, Sanatani, S, Lehman, A, Chen, SRW. Increased Ca2+ Transient Underlies RyR2-Related Left Ventricular Noncompaction. CIRCULATION RESEARCH. 2023; 133(2)DOI:10.1161/CIRCRESAHA.123.322504. PMID:37325910. IF:16.500(Q1/1D).
06/07/2023
Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells
Revilla, G, Ruiz-Auladell, L, Vallverdu, NF, Santamaria, P, Moral, A, Perez, JI, Li, CD, Fuste, V, Lerma, E, Corcoy, R, Pitoia, F, Escola-Gil, JC, Mato, E. Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(13)DOI:10.3390/ijms241311153. PMID:37446330. IF:4.900(Q1/3D).
06/07/2023
Long-Term Oncologic Outcomes of Endoscopic Management of High-Risk Upper Tract Urothelial Carcinoma: The Fundacio Puigvert's Experience
Baboudjian M., Territo A., Gallioli A., Verri P., Aumatell J., Izquierdo P., Uleri A., Tedde A., Basile G., Gaya J.M., Huguet J., Rodriguez-Faba O., Sanguedolce F., Algaba F., Palou J., Breda A.. Long-Term Oncologic Outcomes of Endoscopic Management of High-Risk Upper Tract Urothelial Carcinoma: The Fundacio Puigvert's Experience. JOURNAL OF ENDOUROLOGY. 2023; 37(9)DOI:10.1089/end.2023.0092. PMID:37310884. IF:2.900(Q1/3D).
06/07/2023
Evolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European center
Arguello-Tomas M., Albiol N., Jara P., Garcia-Cadenas I., Redondo S., Esquirol A., Novelli S., Saavedra S., Martino R., Nomdedeu J., Sierra J., Mora A., Moreno C.. Evolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European center. LEUKEMIA & LYMPHOMA. 2023; 64(10)DOI:10.1080/10428194.2023.2232489. PMID:37452739. IF:2.200(Q3/6D).